Literature DB >> 2550852

Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie.

M E Bruce1, P A McBride, C F Farquhar.   

Abstract

Widespread immunostaining of PrP protein was demonstrated in scrapie mouse brain, distributed diffusely in the neuropil and focally in amyloid plaques, microglia and 2-5 microns structures resembling neuronal processes. With the 87V scrapie strain, which produces focal vacuolation in particular areas, PrP pathology was precisely targeted to these same areas, predating vacuolar degeneration by at least several weeks. On the other hand, both vacuolar and PrP changes were widely distributed throughout the brain with the ME7 scrapie strain. It is likely that the precise targeting of PrP pathology, followed by vacuolar degeneration, reflects an underlying targeting and localised replication of infectious agent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550852     DOI: 10.1016/0304-3940(89)90298-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  80 in total

1.  Cultured cell sublines highly susceptible to prion infection.

Authors:  P J Bosque; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.

Authors:  L Zulianello; K Kaneko; M Scott; S Erpel; D Han; F E Cohen; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Conformation-dependent high-affinity monoclonal antibodies to prion proteins.

Authors:  Larry H Stanker; Ana V Serban; Elisa Cleveland; Robert Hnasko; Azucena Lemus; Jiri Safar; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

5.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

6.  Spreading of prions from the immune to the peripheral nervous system: a potential implication of dendritic cells.

Authors:  Gauthier Dorban; Valérie Defaweux; Ernst Heinen; Nadine Antoine
Journal:  Histochem Cell Biol       Date:  2010-03-18       Impact factor: 4.304

Review 7.  The search for scrapie agent nucleic acid.

Authors:  J M Aiken; R F Marsh
Journal:  Microbiol Rev       Date:  1990-09

Review 8.  Nucleic acid-free mutation of prion strains.

Authors:  Glenn C Telling
Journal:  Prion       Date:  2010-10-19       Impact factor: 3.931

9.  Scrapie-associated prion protein accumulates in astrocytes during scrapie infection.

Authors:  J F Diedrich; P E Bendheim; Y S Kim; R I Carp; A T Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

10.  Diagnosis of human prion disease.

Authors:  Jiri G Safar; Michael D Geschwind; Camille Deering; Svetlana Didorenko; Mamta Sattavat; Henry Sanchez; Ana Serban; Martin Vey; Henry Baron; Kurt Giles; Bruce L Miller; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.